Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection
PROJECT LEADER
TEAM MEMBERS
Joseph, PK (Mr Philip)
Department
Research Outputs
- Whole person HIV services: a social science approach
- Daily Oral Pre-exposure Prophylaxis (PrEP) continuation among women from Durban, South Africa, who initiated PrEP as standard of care for HIV prevention in a clinical trial
- High levels of pretreatment HIV-1 drug resistance mutations among South African women who acquired HIV during a prospective study
- Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: a mixed-methods evaluation
- Pilot testing two versions of a social network intervention to increase HIV testing and case-finding among men in South Africa's generalized HIV epidemic
- STI prevalence, partner notification and HIV risk perception in a cohort of women completing STI screening as part of a safer conception study
- Diagnostic accuracy of computer-aided detection of tuberculosis on chest X-rays and C-reactive protein as tuberculosis triage tests at health facilities in Lesotho and South Africa: 2021-2022
- Diagnostic accuracy of point-of-care VISITECT CD4 Advanced Disease compared to Alere Pima CD4, performed at point-of-care within the advanced HIV disease care package
- Prevention product profiles for future options, including long-acting PrEP formulations and products: person-centred design choice in HIV prevention
- A qualitative exploration of sexually transmitted infection (STI) partner notification preferences and practices among women planning for pregnancy and offered HIV pre-exposure prophylaxis in Durban, South Africa